Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.

Westdorp, Harm

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. [electronic resource] - Journal for immunotherapy of cancer 11 2019 - 302 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

2051-1426

10.1186/s40425-019-0787-6 doi


Aged
Antigens, Neoplasm--immunology
Cancer Vaccines
Dendritic Cells--immunology
Humans
Kaplan-Meier Estimate
Male
Membrane Proteins--immunology
Middle Aged
Mucin-1--immunology
Neoplasm Proteins--immunology
Prostatic Neoplasms, Castration-Resistant--immunology
Skin--immunology
T-Lymphocytes--immunology
Treatment Outcome
Vaccination--adverse effects